Airsupra (PT027) approved in US for asthma
11 January 2023 13:00 GMT Airsupra (PT027) approved in the US for asthma First and only rescue medication approved in the US for as-needed use to reduce risk of asthma exacerbations Airsupra (albuterol/budesonide), formerly known as PT027, has been approved in the US for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older. The approval by the Food and Drug Administration (FDA) was based on results from the MANDALA and DENALI Phase III trials.[1,2] In MANDALA, Airsupra significantly